Literature DB >> 10102851

Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer.

M Bredin1, J Corner, M Krishnasamy, H Plant, C Bailey, R A'Hern.   

Abstract

OBJECTIVE: To evaluate the effectiveness of nursing intervention for breathlessness in patients with lung cancer.
DESIGN: Patients diagnosed with lung cancer participated in a multicentre randomised controlled trial where they either attended a nursing clinic offering intervention for their breathlessness or received best supportive care. The intervention consisted of a range of strategies combining breathing control, activity pacing, relaxation techniques, and psychosocial support. Best supportive care involved receiving standard management and treatment available for breathlessness, and breathing assessments. Participants completed a range of self assessment questionnaires at baseline, 4 weeks, and 8 weeks.
SETTING: Nursing clinics within 6 hospital settings in the United Kingdom. PARTICIPANTS: 119 patients diagnosed with small cell or non-small cell lung cancer or with mesothelioma who had completed first line treatment for their disease and reported breathlessness. OUTCOME MEASURES: Visual analogue scales measuring distress due to breathlessness, breathlessness at best and worst, WHO performance status scale, hospital anxiety and depression scale, and Rotterdam symptom checklist.
RESULTS: The intervention group improved significantly at 8 weeks in 5 of the 11 items assessed: breathlessness at best, WHO performance status, levels of depression, and two Rotterdam symptom checklist measures (physical symptom distress and breathlessness) and showed slight improvement in 3 of the remaining 6 items.
CONCLUSION: Most patients who completed the study had a poor prognosis, and breathlessness was typically a symptom of their deteriorating condition. Patients who attended nursing clinics and received the breathlessness intervention experienced improvements in breathlessness, performance status, and physical and emotional states relative to control patients.

Entities:  

Mesh:

Year:  1999        PMID: 10102851      PMCID: PMC27809          DOI: 10.1136/bmj.318.7188.901

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  7 in total

1.  Non-pharmacological intervention for breathlessness in lung cancer.

Authors:  J Corner; H Plant; R A'Hern; C Bailey
Journal:  Palliat Med       Date:  1996-10       Impact factor: 4.762

2.  Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group.

Authors:  M F Muers; C E Round
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

3.  A new approach to the analysis of clinical drug trials with withdrawals.

Authors:  A L Gould
Journal:  Biometrics       Date:  1980-12       Impact factor: 2.571

4.  The experience of dyspnea in late-stage cancer. Patients' and nurses' perspectives.

Authors:  D K Roberts; S E Thorne; C Pearson
Journal:  Cancer Nurs       Date:  1993-08       Impact factor: 2.592

5.  The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.

Authors:  B Bergman; N K Aaronson; S Ahmedzai; S Kaasa; M Sullivan
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

6.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

7.  Measuring symptoms in terminal cancer: are pain and dyspnoea controlled?

Authors:  I Higginson; M McCarthy
Journal:  J R Soc Med       Date:  1989-05       Impact factor: 18.000

  7 in total
  47 in total

Review 1.  Statement on malignant mesothelioma in the United Kingdom.

Authors: 
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

2.  How well is the clinical importance of study results reported? An assessment of randomized controlled trials.

Authors:  K B Chan; M Man-Son-Hing; F J Molnar; A Laupacis
Journal:  CMAJ       Date:  2001-10-30       Impact factor: 8.262

3.  Integrated medicine. Many orthopaedic surgeons do not think of patients just as malfunctioning elbows.

Authors:  A Carr
Journal:  BMJ       Date:  2001-06-16

4.  Pleasing both authors and readers. A combination of short print articles and longer electronic ones may help us do this.

Authors:  T Delamothe; M Müllner; R Smith
Journal:  BMJ       Date:  1999-04-03

5.  The lived experience of breathlessness and its implications for care: a qualitative comparison in cancer, COPD, heart failure and MND.

Authors:  Marjolein H Gysels; Irene J Higginson
Journal:  BMC Palliat Care       Date:  2011-10-17       Impact factor: 3.234

6.  Lung cancer and rehabilitation--what are the barriers? Results of a questionnaire survey and the development of regional lung cancer rehabilitation standards and guidelines.

Authors:  Amara Callistus Nwosu; Joanne L Bayly; Kathryn E Gaunt; Catriona R Mayland
Journal:  Support Care Cancer       Date:  2012-04-27       Impact factor: 3.603

7.  BTS statement on malignant mesothelioma in the UK, 2007.

Authors: 
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

Review 8.  WITHDRAWN: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  Claudia Bausewein; Sara Booth; Marjolein Gysels; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

Review 9.  Management of refractory breathlessness in patients with advanced cancer.

Authors:  Steffen T Simon; Claudia Bausewein
Journal:  Wien Med Wochenschr       Date:  2009-12

Review 10.  Palliative management of refractory dyspnea in COPD.

Authors:  Hope E Uronis; David C Currow; Amy P Abernethy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.